367 related articles for article (PubMed ID: 33653692)
21. Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2.
Malik R; Luong T; Cao X; Han B; Shah N; Franco-Barraza J; Han L; Shenoy VB; Lelkes PI; Cukierman E
Matrix Biol; 2019 Aug; 81():50-69. PubMed ID: 30412725
[TBL] [Abstract][Full Text] [Related]
22. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
23. Cell polarity proteins promote macropinocytosis in response to metabolic stress.
Lambies G; Lee SW; Duong-Polk K; Aza-Blanc P; Maganti S; Dawson DW; Commisso C
bioRxiv; 2024 Jan; ():. PubMed ID: 38293142
[TBL] [Abstract][Full Text] [Related]
24. The role of stromal cancer-associated fibroblasts in pancreatic cancer.
von Ahrens D; Bhagat TD; Nagrath D; Maitra A; Verma A
J Hematol Oncol; 2017 Mar; 10(1):76. PubMed ID: 28351381
[TBL] [Abstract][Full Text] [Related]
25. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes.
Pausch TM; Aue E; Wirsik NM; Freire Valls A; Shen Y; Radhakrishnan P; Hackert T; Schneider M; Schmidt T
Sci Rep; 2020 Mar; 10(1):5420. PubMed ID: 32214219
[TBL] [Abstract][Full Text] [Related]
26. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
[TBL] [Abstract][Full Text] [Related]
27. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
Davidson SM; Jonas O; Keibler MA; Hou HW; Luengo A; Mayers JR; Wyckoff J; Del Rosario AM; Whitman M; Chin CR; Condon KJ; Lammers A; Kellersberger KA; Stall BK; Stephanopoulos G; Bar-Sagi D; Han J; Rabinowitz JD; Cima MJ; Langer R; Vander Heiden MG
Nat Med; 2017 Feb; 23(2):235-241. PubMed ID: 28024083
[TBL] [Abstract][Full Text] [Related]
28. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
29. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
30. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
31. Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.
Xiao Q; Zhou D; Rucki AA; Williams J; Zhou J; Mo G; Murphy A; Fujiwara K; Kleponis J; Salman B; Wolfgang CL; Anders RA; Zheng S; Jaffee EM; Zheng L
Cancer Res; 2016 Sep; 76(18):5395-404. PubMed ID: 27496707
[TBL] [Abstract][Full Text] [Related]
32. Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer.
Honselmann KC; Finetti P; Birnbaum DJ; Monsalve CS; Wellner UF; Begg SKS; Nakagawa A; Hank T; Li A; Goldsworthy MA; Sharma H; Bertucci F; Birnbaum D; Tai E; Ligorio M; Ting DT; Schilling O; Biniossek ML; Bronsert P; Ferrone CR; Keck T; Mino-Kenudson M; Lillemoe KD; Warshaw AL; Fernández-Del Castillo C; Liss AS
Mol Cancer Res; 2020 Dec; 18(12):1889-1902. PubMed ID: 32873625
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia Potentiates the Inflammatory Fibroblast Phenotype Promoted by Pancreatic Cancer Cell-Derived Cytokines.
Schwörer S; Cimino FV; Ros M; Tsanov KM; Ng C; Lowe SW; Carmona-Fontaine C; Thompson CB
Cancer Res; 2023 May; 83(10):1596-1610. PubMed ID: 36912618
[TBL] [Abstract][Full Text] [Related]
34. STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer.
Lefler JE; MarElia-Bennett CB; Thies KA; Hildreth BE; Sharma SM; Pitarresi JR; Han L; Everett C; Koivisto C; Cuitino MC; Timmers CD; O'Quinn E; Parrish M; Romeo MJ; Linke AJ; Hobbs GA; Leone G; Guttridge DC; Zimmers TA; Lesinski GB; Ostrowski MC
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35803738
[TBL] [Abstract][Full Text] [Related]
35. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.
Ijichi H; Chytil A; Gorska AE; Aakre ME; Bierie B; Tada M; Mohri D; Miyabayashi K; Asaoka Y; Maeda S; Ikenoue T; Tateishi K; Wright CV; Koike K; Omata M; Moses HL
J Clin Invest; 2011 Oct; 121(10):4106-17. PubMed ID: 21926469
[TBL] [Abstract][Full Text] [Related]
36. NetrinG1
Raghavan KS; Francescone R; Franco-Barraza J; Gardiner JC; Vendramini-Costa DB; Luong T; Pourmandi N; Andren A; Kurimchak A; Ogier C; Campbell PM; Duncan JS; Lyssiotis CA; Languino LR; Cukierman E
Cancer Res Commun; 2022 Sep; 2(9):1017-1036. PubMed ID: 36310768
[TBL] [Abstract][Full Text] [Related]
37. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.
Belle JI; Sen D; Baer JM; Liu X; Lander VE; Ye J; Sells BE; Knolhoff BL; Faiz A; Kang LI; Qian G; Fields RC; Ding L; Kim H; Provenzano PP; Stewart SA; DeNardo DG
Cancer Discov; 2024 Jul; 14(7):1324-1355. PubMed ID: 38683144
[TBL] [Abstract][Full Text] [Related]
38. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts.
Tjomsland V; Spångeus A; Välilä J; Sandström P; Borch K; Druid H; Falkmer S; Falkmer U; Messmer D; Larsson M
Neoplasia; 2011 Aug; 13(8):664-75. PubMed ID: 21847358
[TBL] [Abstract][Full Text] [Related]
40. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]